Handelsbanken Fonder AB Has $1.06 Million Stake in Encompass Health Co. (NYSE:EHC)

Handelsbanken Fonder AB raised its position in shares of Encompass Health Co. (NYSE:EHC) by 1.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 15,953 shares of the company’s stock after purchasing an additional 300 shares during the quarter. Handelsbanken Fonder AB’s holdings in Encompass Health were worth $1,064,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of EHC. Treasurer of the State of North Carolina lifted its stake in Encompass Health by 0.5% in the 3rd quarter. Treasurer of the State of North Carolina now owns 48,339 shares of the company’s stock worth $3,246,000 after acquiring an additional 231 shares in the last quarter. Personal CFO Solutions LLC increased its holdings in shares of Encompass Health by 5.2% in the 3rd quarter. Personal CFO Solutions LLC now owns 6,231 shares of the company’s stock valued at $419,000 after purchasing an additional 310 shares during the period. EverSource Wealth Advisors LLC lifted its position in shares of Encompass Health by 14.7% in the third quarter. EverSource Wealth Advisors LLC now owns 2,713 shares of the company’s stock worth $182,000 after purchasing an additional 347 shares in the last quarter. Verdence Capital Advisors LLC boosted its holdings in shares of Encompass Health by 7.1% during the third quarter. Verdence Capital Advisors LLC now owns 5,580 shares of the company’s stock worth $375,000 after purchasing an additional 370 shares during the period. Finally, PNC Financial Services Group Inc. increased its stake in Encompass Health by 5.7% in the 3rd quarter. PNC Financial Services Group Inc. now owns 7,298 shares of the company’s stock valued at $490,000 after buying an additional 396 shares during the period. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on EHC shares. Mizuho lifted their target price on shares of Encompass Health from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Thursday. Truist Financial boosted their target price on Encompass Health from $82.00 to $86.00 and gave the company a “buy” rating in a research note on Friday, February 9th. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research note on Wednesday, February 7th. Raymond James reissued a “strong-buy” rating and issued a $95.00 price target (up previously from $85.00) on shares of Encompass Health in a research note on Friday. Finally, Barclays increased their price objective on Encompass Health from $101.00 to $108.00 and gave the stock an “overweight” rating in a report on Thursday. Eight research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $88.13.

Encompass Health Stock Performance

EHC opened at $82.47 on Monday. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.28 and a current ratio of 1.37. The company has a market cap of $8.26 billion, a PE ratio of 22.29, a price-to-earnings-growth ratio of 1.50 and a beta of 0.94. The stock has a 50-day moving average of $78.25 and a 200-day moving average of $70.96. Encompass Health Co. has a 52-week low of $57.55 and a 52-week high of $85.84.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.93 by $0.19. The firm had revenue of $1.32 billion during the quarter, compared to analysts’ expectations of $1.27 billion. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The company’s revenue was up 13.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.88 earnings per share. As a group, equities research analysts forecast that Encompass Health Co. will post 4.1 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were given a dividend of $0.15 per share. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $0.60 annualized dividend and a dividend yield of 0.73%. Encompass Health’s dividend payout ratio is presently 16.22%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.